Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_assertion description "[These technologies have aided in the advancement of cancer vaccine development, as illustrated in examples including NY-ESO-1 originally defined by SEREX, and HER2/neu peptides analyzed via high-throughput epitope prediction methods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_assertion evidence source_evidence_literature NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_assertion SIO_000772 21732821 NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_assertion wasDerivedFrom befree-20150227 NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_assertion wasGeneratedBy ECO_0000203 NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP981048.RAlJlSHWvtCUS5JbNT7z15aQvH-wxP0LV8JnDHZOjn4s4130_provenance.